8JMI
 
 | |
8JMA
 | |
8JME
 | |
8JMH
 | |
3U4U
 | | Casein kinase 2 in complex with AZ-Inhibitor | | 分子名称: | 3-{5-(acetylamino)-3-[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]-1H-indol-1-yl}propanoic acid, CHLORIDE ION, Casein kinase II subunit alpha | | 著者 | Larsen, N.A, Dowling, J. | | 登録日 | 2011-10-10 | | 公開日 | 2012-08-22 | | 最終更新日 | 2024-02-28 | | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | | 主引用文献 | Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization.
ACS Med Chem Lett, 3, 2012
|
|
9FKY
 | | Discovery of a Series of Covalent, Cell Active Bfl-1 Inhibitors | | 分子名称: | Bcl-2-related protein A1, ~{N}-[4-[(1~{R},3~{R})-3-azanylcyclopentyl]oxyphenyl]-~{N}-[(1~{S})-1-[3-cyano-4-(trifluoromethyl)phenyl]ethyl]propanamide | | 著者 | Hargreaves, D. | | 登録日 | 2024-06-04 | | 公開日 | 2024-10-02 | | 最終更新日 | 2024-10-09 | | 実験手法 | X-RAY DIFFRACTION (1.557 Å) | | 主引用文献 | Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors.
J.Med.Chem., 67, 2024
|
|
9FKZ
 | | Discovery of a Series of Covalent, Cell Active Bfl-1 Inhibitors | | 分子名称: | Bcl-2-related protein A1, ~{N}-[4-[(1~{R},3~{R})-3-azanylcyclopentyl]oxyphenyl]-~{N}-[(4-chlorophenyl)methyl]prop-2-enamide | | 著者 | Hargreaves, D. | | 登録日 | 2024-06-04 | | 公開日 | 2024-10-02 | | 最終更新日 | 2024-10-09 | | 実験手法 | X-RAY DIFFRACTION (1.684 Å) | | 主引用文献 | Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors.
J.Med.Chem., 67, 2024
|
|
9GIR
 | | BFL1 covalently bound to inhibitor compound 39 | | 分子名称: | Bcl-2-related protein A1, ~{N}-[4-[(1~{R},3~{R})-3-[[(3~{R})-1,1-bis(oxidanylidene)thiolan-3-yl]carbamoylamino]cyclopentyl]oxy-3-chloranyl-phenyl]-~{N}-[(1~{S})-1-(4-chlorophenyl)ethyl]propanamide | | 著者 | Cottee, M.A. | | 登録日 | 2024-08-19 | | 公開日 | 2024-12-18 | | 最終更新日 | 2025-01-08 | | 実験手法 | X-RAY DIFFRACTION (1.075 Å) | | 主引用文献 | Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors.
J.Med.Chem., 67, 2024
|
|
9GIQ
 | | BFL1 covalently bound to inhibitor compound 13 | | 分子名称: | (2S,3S)-butane-2,3-diol, Bcl-2-related protein A1, ~{N}-[4-[(1~{R},3~{R})-3-azanylcyclopentyl]oxyphenyl]-~{N}-[(1~{S})-1-(4-chlorophenyl)-3-methyl-3-oxidanyl-butyl]propanamide | | 著者 | Cottee, M.A. | | 登録日 | 2024-08-19 | | 公開日 | 2024-12-18 | | 最終更新日 | 2025-01-08 | | 実験手法 | X-RAY DIFFRACTION (1.421 Å) | | 主引用文献 | Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors.
J.Med.Chem., 67, 2024
|
|
9GIP
 | | BFL1 covalently bound to inhibitor compound 7 | | 分子名称: | Bcl-2-related protein A1, ~{N}-[4-[(1~{R},3~{R})-3-azanylcyclopentyl]oxyphenyl]-~{N}-[(1~{S})-1-(4-chlorophenyl)ethyl]propanamide | | 著者 | Hargreaves, D, Cottee, M.A. | | 登録日 | 2024-08-19 | | 公開日 | 2024-12-18 | | 最終更新日 | 2025-01-08 | | 実験手法 | X-RAY DIFFRACTION (1.463 Å) | | 主引用文献 | Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors.
J.Med.Chem., 67, 2024
|
|
9GIT
 | | BFL1 covalently bound to inhibitor compound 43 | | 分子名称: | (3~{S})-3-[[4-[(1~{R},3~{R})-3-[[(3~{R})-1,1-bis(oxidanylidene)thiolan-3-yl]carbamoylamino]cyclopentyl]oxy-3-fluoranyl-phenyl]-propanoyl-amino]-3-(4-chlorophenyl)propanamide, Bcl-2-related protein A1 | | 著者 | Cottee, M.A. | | 登録日 | 2024-08-19 | | 公開日 | 2024-12-18 | | 最終更新日 | 2025-01-08 | | 実験手法 | X-RAY DIFFRACTION (1.145 Å) | | 主引用文献 | Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors.
J.Med.Chem., 67, 2024
|
|
9GIS
 | | BFL1 covalently bound to inhibitor compound 17 | | 分子名称: | Bcl-2-related protein A1, ~{N}-[(1~{S})-1-(4-chlorophenyl)ethyl]-~{N}-[4-[(1~{R},3~{R})-3-[[(3~{S})-pyrrolidin-3-yl]carbamoylamino]cyclopentyl]oxyphenyl]propanamide | | 著者 | Cottee, M.A. | | 登録日 | 2024-08-19 | | 公開日 | 2024-12-18 | | 最終更新日 | 2025-01-08 | | 実験手法 | X-RAY DIFFRACTION (1.387 Å) | | 主引用文献 | Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors.
J.Med.Chem., 67, 2024
|
|
9GIO
 | |
9FL0
 | |
9J38
 | | human KCNQ5-CaM in apo state | | 分子名称: | Calmodulin-1, Potassium voltage-gated channel subfamily KQT member 5 | | 著者 | Yang, Z, Guo, J. | | 登録日 | 2024-08-08 | | 公開日 | 2025-04-16 | | 最終更新日 | 2025-05-14 | | 実験手法 | ELECTRON MICROSCOPY (2.4 Å) | | 主引用文献 | Phosphatidylinositol 4,5-bisphosphate activation mechanism of human KCNQ5.
Proc.Natl.Acad.Sci.USA, 122, 2025
|
|
6LG2
 | | VanR bound to Vanillate | | 分子名称: | 4-HYDROXY-3-METHOXYBENZOATE, Predicted transcriptional regulators | | 著者 | He, Y, Bharath, S.R, Song, H. | | 登録日 | 2019-12-04 | | 公開日 | 2020-02-12 | | 最終更新日 | 2023-11-22 | | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | | 主引用文献 | Developing a highly efficient hydroxytyrosol whole-cell catalyst by de-bottlenecking rate-limiting steps.
Nat Commun, 11, 2020
|
|
7BV7
 | | INTS3 complexed with INTS6 | | 分子名称: | Integrator complex subunit 3, Integrator complex subunit 6 | | 著者 | Jia, Y, Bharath, S.R, Song, H. | | 登録日 | 2020-04-09 | | 公開日 | 2021-07-14 | | 最終更新日 | 2024-05-29 | | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | | 主引用文献 | Crystal structure of the INTS3/INTS6 complex reveals the functional importance of INTS3 dimerization in DSB repair.
Cell Discov, 7, 2021
|
|
